| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.43B | 13.43B | 10.10B | 9.19B | 7.08B | 6.86B |
| Gross Profit | 12.42B | 13.30B | 9.58B | 8.45B | 6.57B | 6.43B |
| EBITDA | 6.36B | 7.02B | 4.70B | 3.89B | 2.61B | 2.38B |
| Net Income | 4.14B | 4.55B | 3.33B | 3.22B | 2.19B | 1.79B |
Balance Sheet | ||||||
| Total Assets | 133.14B | 125.05B | 118.19B | 88.32B | 74.10B | 68.55B |
| Cash, Cash Equivalents and Short-Term Investments | 8.45B | 12.12B | 8.85B | 5.78B | 6.37B | 5.11B |
| Total Debt | 1.03B | 1.13B | 2.23B | 2.10B | 2.06B | 1.70B |
| Total Liabilities | 115.98B | 107.63B | 104.08B | 76.34B | 64.85B | 61.23B |
| Stockholders Equity | 17.16B | 17.41B | 14.12B | 11.97B | 9.25B | 7.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.99B | 5.11B | 692.00M | 578.00M | 1.50B |
| Operating Cash Flow | 0.00 | 6.47B | 5.17B | 1.32B | 849.00M | 1.73B |
| Investing Cash Flow | 0.00 | -607.00M | -329.00M | -729.00M | -146.00M | -510.00M |
| Financing Cash Flow | 0.00 | -2.58B | -1.28B | -590.00M | 73.00M | -151.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥88.20B | 6.63 | ― | 5.75% | 10.85% | 30.77% | |
80 Outperform | ¥198.45B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
74 Outperform | ¥253.71B | 12.14 | 14.00% | 5.13% | 3.27% | -1.81% | |
72 Outperform | ¥30.91B | 6.33 | ― | 3.91% | -11.56% | -26.01% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥46.35B | 10.12 | ― | 4.36% | 1.14% | -16.88% | |
43 Neutral | ¥178.25B | 13.27 | 7.26% | 4.16% | 14.69% | -114.36% |